Urolyte Injection

Urolyte Injection belongs to a class of drugs called antithrombotic agents used to dissolve harmful blood clots in blood vessels. It is used in conditions such as peripheral vascular thromboembolism (blood clot in a large vein), cerebral thrombosis (blood clot in venous sinuses of the brain), cerebral infarction (stroke), myocardial infarction (heart attack),  and pulmonary embolism (blood clots in the lungs).

Urolyte Injection contains urokinase that works by converting plasminogen to the enzyme plasmin. Plasmin degrades fibrin clots as well as fibrinogen and some other plasma proteins. It effectively dissolves the blood clots, restoring the blood flow to the affected area.

Urolyte Injection will be administered by a healthcare professional. In some cases, Urolyte Injection may cause unusual bleeding, nausea, vomiting, and loss of appetite. Most of these side effects do not necessitate medical treatment and fade away with time. Please visit your doctor if the side effects persist or worsen.

If you are pregnant or breastfeeding, inform your doctor before taking Urolyte Injection. Keep your doctor updated on your medical condition and medications to rule out any potential interactions. Avoid consuming alcohol along with Urolyte Injection as it could increase the risk of bleeding. Urolyte Injection should not be given to children because its safety and effectiveness have not been proven.

Urolyte Injection is used in the treatment of blood clots (thrombus). The detailed uses of Urolyte Injection are as follows:

• Treats Blood Clots (Thrombus): Urolyte Injection helps dissolve harmful blood clots within blood vessels, thereby restoring normal blood flow.
• Treats Peripheral Vascular Thromboembolism: Urolyte Injection is used to treat blood clots in large veins in the limbs, thus preventing complications like deep vein thrombosis.
• Manages Cerebral Thrombosis: Urolyte Injection is used to treat blood clots in the venous sinuses of the brain, helping to reduce pressure and prevent further neurological damage.
• Treats Cerebral Infraction (Ischemic Stroke): Urolyte Injection helps restore blood flow to the brain by dissolving blood clots that cause stroke.
• Treats Pulmonary Embolism: Urolyte Injection is used to dissolve blood clots in the lungs, restoring blood supply, enhancing oxygen exchange, and preventing lung tissue damage.
• Used in Myocardial Infarction (Heart Attack) : Urolyte Injection may be used in certain cases of heart attack to dissolve the clots causing blockage in the coronary arteries.

• Follow your doctor’s instructions on the dosage and timing of this medication.
• Urolyte Injection should be administered by a nurse or doctor.
• Do not self-administer.

Urolyte Injection belongs to a class of drugs known as antithrombotic medications. Urolyte Injection contains urokinase. It works by dissolving or lysing the harmful or unwanted blood clots in the blood vessels. Thus it restores the blood flow to the affected blood vessels, preventing various illnesses caused by blood clots. It is used in conditions such as peripheral vascular thromboembolism (blood clot in a large vein), cerebral thrombosis (blood clot in venous sinuses of the brain), cerebral infarction (stroke), myocardial infarction (heart attack),  and pulmonary embolism (blood clots in the lungs).

Before taking Urolyte Injection, tell your doctor if you are pregnant or breastfeeding. Urolyte Injection should be used with caution in elderly people because they are at significant risk of bleeding. If you have active tuberculosis, stomach ulcers, severe uncontrolled arterial hypertension, bleeding abnormalities, severe hepatic or renal diseases, inform your doctor before taking Urolyte Injection. Also, let your doctor know if you have had a recent cerebrovascular accident, as well as intracranial or intraspinal surgery. Inform your doctor that you take Urolyte Injection if are due to undergo surgery. You should avoid alcohol because it increases the risk of bleeding. Urolyte Injection is not recommended for children since its safety and effectiveness have not been proven.